Timing of Development of Symptomatic Brain Metastases from Non-Small Cell Lung Cancer: Impact on Symptoms, Treatment, and Survival in the Era of Molecular Treatments.
Stephanie T JüngerPetra SchödelDaniel RuessMaximilian RugeJulia-Sarita BrandMaike WittersheimMarie-Lisa EichNils Ole SchmidtRoland GoldbrunnerStefan J GrauMartin ProescholdtPublished in: Cancers (2020)
Early BM presentation was not associated with worse OS in NSCLC BM patients.
Keyphrases
- brain metastases
- small cell lung cancer
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- peritoneal dialysis
- advanced non small cell lung cancer
- patient reported outcomes
- physical activity
- patient reported
- epidermal growth factor receptor
- smoking cessation
- tyrosine kinase